연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1507 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, Young-Woo | Kim, YW | 6 | Natl Canc Ctr, Ctr Gastr Canc Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, Jin Young | Kim, JY | 7 | Keimyung Univ Dongsan Hosp, Dept Internal Med, Div Hemato Oncol, Daegu, South Korea | JWP-3629-2024 | Kim, Jin Il | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Ryu, Min-Hee | Ryu, MH | 8 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea | 0000-0002-1033-1263 | Ryu, Min-Hee | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Rha, Sun Young | Rha, SY | 9 | Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea | 0000-0002-2512-4531 | Rha, Sun Young | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Chung, Ik Joo | Chung, IJ | 10 | Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Internal Med, Med Sch, Jeonnam, South Korea | 0000-0003-0479-8067 | Chung, Ik-Joo | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, In-Ho | Kim, IH | 11 | Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Med Oncol, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Oh, Sang Cheul | Oh, SC | 12 | Korea Univ Guro Hosp, Dept Internal Med, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Park, Young Soo | Park, YS | 13 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Cheong, Jae-Ho | Cheong, JH | 14 | Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Dept Surg, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Jeong, Oh | Jeong, O | 15 | Chonnam Natl Univ, Dept Surg, Med Sch, Hwasun, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Heo, Mi Hwa | Heo, MH | 16 | Keimyung Univ Dongsan Hosp, Dept Internal Med, Div Hemato Oncol, Daegu, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, Hark Kyun | Kim, HK | 17 | Natl Canc Ctr, Ctr Gastr Canc Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Park, Chohyun | Park, C | 18 | Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Yoo, Chang Hak | Yoo, CH | 19 | Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Surg, Sch Med, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kang, Seok Yun | Kang, SY | 20 | Ajou Univ, Dept Hematol Oncol, Sch Med, Suwon, South Korea | ykkang@amc.seoul.kr; |
페이지 이동: